ZyVet' Animal Health, a leader in affordable generic pharmaceuticals for animals and a wholly owned subsidiary of Zydus Pharmaceuticals (USA) Inc., itself a wholly owned subsidiary of Zydus Lifesciences, a global innovation led healthcare company, announces the launch of first veterinary approved generic of Furosemide Tablets, a critical therapy for managing congestive heart failure and chronic fluid retention in dogs and cats.

Furosemide remains the most widely used veterinary diuretic for reducing edema and pulmonary congestion due to cardiac, renal, or systemic disease. ZyVet's formulation offers veterinarians a consistent, cost-effective solution that supports long-term therapy, without compromising dosing flexibility or product availability.

Powered by Capital Market - Live News